Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.9160
-0.0065 (-0.70%)
At close: Jun 27, 2025, 4:00 PM
0.9020
-0.0140 (-1.53%)
After-hours: Jun 27, 2025, 4:10 PM EDT
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $36.95 million as of June 27, 2025. Its market cap has decreased by -50.18% in one year.
Market Cap
36.95M
Enterprise Value
-50.25M
1-Year Change
-50.18%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $36.95M, a decrease of -93.62%. That is a compound annual growth rate of -48.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 37.21M | -23.42% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |